Market Value1,667,158,944
Total Holdings63
File Date2024-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
MRK / Merck & Co., Inc.
SANA / Sana Biotechnology, Inc.
AXSM / Axsome Therapeutics, Inc.
DXCM / DexCom, Inc.
PRAX / Praxis Precision Medicines, Inc.
TMO / Thermo Fisher Scientific Inc.
VRTX / Vertex Pharmaceuticals Incorporated
ACHC / Acadia Healthcare Company, Inc.
ZBH / Zimmer Biomet Holdings, Inc.
IRTC / iRhythm Technologies, Inc.
SYK / Stryker Corporation
EW / Edwards Lifesciences Corporation
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
XENE / Xenon Pharmaceuticals Inc.
EPIX / ESSA Pharma Inc.
HUM / Humana Inc.
BLUE / bluebird bio, Inc.
BDX / Becton, Dickinson and Company
US516544AB96 / CONV. NOTE
US09061GAH48 / BioMarin Pharmaceutical, Inc. Bond
ROIV / Roivant Sciences Ltd.
KRTX / Karuna Therapeutics, Inc.
THC / Tenet Healthcare Corporation
ICLR / ICON Public Limited Company
PRTA / Prothena Corporation plc
IQV / IQVIA Holdings Inc.
SNDX / Syndax Pharmaceuticals, Inc.
GBIO / Generation Bio Co.
IMGN / ImmunoGen, Inc.
CAH / Cardinal Health, Inc.
EDIT / Editas Medicine, Inc.
RCUS / Arcus Biosciences, Inc.
SGEN / Seagen Inc
PNT / POINT Biopharma Global Inc.
VRDN / Viridian Therapeutics, Inc.
AKRO / Akero Therapeutics, Inc.
NARI / Inari Medical, Inc. Put
LNTH / Lantheus Holdings, Inc.
ELV / Elevance Health, Inc.
DHR / Danaher Corporation
BMRN / BioMarin Pharmaceutical Inc. Call
MCK / McKesson Corporation
HCA / HCA Healthcare, Inc.
ALKS / Alkermes plc
ABBV / AbbVie Inc.
CYTK / Cytokinetics, Incorporated
IMVT / Immunovant, Inc.
BSX / Boston Scientific Corporation
CNC / Centene Corporation
ISRG / Intuitive Surgical, Inc.
LLY / Eli Lilly and Company
EYPT / EyePoint Pharmaceuticals, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
BMRN / BioMarin Pharmaceutical Inc.
IOBT / IO Biotech, Inc.
MOH / Molina Healthcare, Inc.
UNH / UnitedHealth Group Incorporated
HOWL / Werewolf Therapeutics, Inc.
BIIB / Biogen Inc.
CELC / Celcuity Inc.
PEN / Penumbra, Inc.
CLDX / Celldex Therapeutics, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
US64157FAC77 / Nevro Corp
INBX / Inhibrx Biosciences, Inc.
US23282WAC47 / CONV. NOTE
UHS / Universal Health Services, Inc.
ACLX / Arcellx, Inc.
SGMT / Sagimet Biosciences Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
TSBX / Turnstone Biologics Corp.
SRPT / Sarepta Therapeutics, Inc.
OSCR / Oscar Health, Inc.
CRBU / Caribou Biosciences, Inc.
VEEV / Veeva Systems Inc.
OM / Outset Medical, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
AVTR / Avantor, Inc.
ERAS / Erasca, Inc.
PMVP / PMV Pharmaceuticals, Inc.